Works matching IS 1470269X AND DT 2006 AND VI 6 AND IP 2

Results: 11

Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 89, doi. 10.1038/sj.tpj.6500344

By:

Trepicchio, W. L.;
Essayan, D.;
Hall, S. T.;
Schechter, G.;
Tezak, Z.;
Wang, S. J.;
Weinreich, D.;
Simon, R.

Publication type:

Article

Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 78, doi. 10.1038/sj.tpj.6500345

By:

Salerno, R. A.;
Lesko, L. J.

Publication type:

Article

cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 131, doi. 10.1038/sj.tpj.6500346

By:

Sondhi, S.;
Castellano, J. M.;
Chong, V. Z.;
Rogoza, R. M.;
Skoblenick, K. J.;
Dyck, B. A.;
Gabriele, J.;
Thomas, N.;
Ki, K.;
Pristupa, Z. B.;
Singh, A. N.;
MacCrimmon, D.;
Voruganti, P.;
Foster, J.;
Mishra, R. K.

Publication type:

Article

Sequence diversity and haplotype structure at the human CYP3A cluster.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 105, doi. 10.1038/sj.tpj.6500347

By:

Thompson, E. E.;
Kuttab-Boulos, H.;
Yang, L.;
Roe, B. A.;
Di Rienzo, A.

Publication type:

Article

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 115, doi. 10.1038/sj.tpj.6500348

By:

Kubota, T.;
Nakajima-Taniguchi, C.;
Fukuda, T.;
Funamoto, M.;
Maeda, M.;
Tange, E.;
Ueki, R.;
Kawashima, K.;
Hara, H.;
Fujio, Y.;
Azuma, J.

Publication type:

Article

Apolipoprotein D is associated with long-term outcome in patients with schizophrenia.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 120, doi. 10.1038/sj.tpj.6500350

By:

Hansen, T.;
Hemmingsen, R. P.;
Wang, A. G.;
Olsen, L.;
Timm, S.;
Søeby, K.;
Jakobsen, K. D.;
Fenger, M.;
Parnas, J.;
Rasmussen, H. B.;
Werge, T.

Publication type:

Article

(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 126, doi. 10.1038/sj.tpj.6500352

By:

Ballon, N.;
Leroy, S.;
Roy, C.;
Bourdel, M. C.;
Charles-Nicolas, A.;
Krebs, M. O.;
Poirier, M. F.

Publication type:

Article

Gene expression analysis in a murine model of allergic asthma reveals overlapping disease and therapy dependent pathways in the lung.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 141, doi. 10.1038/sj.tpj.6500357

By:

Follettie, M. T.;
Ellis, D. K.;
Donaldson, D. D.;
Hill, A. A.;
Diesl, V.;
DeClercq, C.;
Sypek, J. P.;
Dorner, A. J.;
Wills-Karp, M.

Publication type:

Article

Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 95, doi. 10.1038/sj.tpj.6500360

By:

Fumagalli, F.;
Racagni, G.;
Riva, M. A.

Publication type:

Article

Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary.

Published in:

Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 82, doi. 10.1038/sj.tpj.6500363

By:

Wang, S-J;
Cohen, N.;
Katz, D. A.;
Ruano, G.;
Shaw, P. M.;
Spear, B.

Publication type:

Article

In This Issue.

Published in:: Pharmacogenomics Journal, 2006, v. 6, n. 2, p. 77, doi. 10.1038/sj.tpj.6500381
Publication type:: Article